T1	p 335 357	healthy young subjects
T2	p 431 461	Five groups of 8 subjects each
T3	i 181 222	potent cholesteryl ester transfer protein
T4	i 230 268	) inhibitor torcetrapib ( CP-529,414 )
T5	i 481 519	placebo ( n=2 ) or torcetrapib ( n=6 )
T6	i 533 565	60 , and 120 mg daily and 120 mg
T7	i 590 603	. Torcetrapib
T8	o 278 331	high-density lipoprotein cholesterol ( HDL-C ) levels
T9	o 693 711	plasma drug levels
T10	o 1001 1025	Total plasma cholesterol
T11	o 1129 1164	low-density lipoprotein cholesterol
T12	o 1349 1361	triglyceride